Given that it has a beta of 1.71, we can surmise that the China Pharma Holdings share price has been fairly sensitive to market volatility (over the last 5 years).
Analysts have been projecting $4.5 as a low price target for the stock while placing it at a high target of $4.5.
ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. Find the latest China Pharma Holdings, Inc. (CPHI) stock quote, history, news and other vital information to help you with your stock trading and investing. For futures contracts, the measurement uses the past 100-trading sessions.
Marketing Sentinel is a free online newspaper packed with exclusive content, news, articles and much more!
The information agency "Marketing Sentinel" was established at the end of 2004. China Pharma Holdings, Inc.’s shares saw a change of 117.48% in year-to-date performance and have moved 1.9% in past 5-day. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Get today's China Pharma Holdings Inc stock price and latest CPHI news as well as China Pharma real-time stock quotes, technical analysis, full financials and more. It follows that stock’s current price would jump +782.35% in reaching the projected high whereas dropping to the targeted low would mean a loss of 782.35% for stock’s current value.Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.1% during past 5 years. China Pharma Holdings, Inc. () Stock Market info Recommendations: Buy or sell China Pharma Holdings, Inc. stock? Renaissance Technologies, LLC is the top institutional holder at CPHI for having 950.08 Thousand shares of worth $478.75 Thousand. If the total is less than zero, then this is a "Sell".To keep the results in a more logical format, we factor the overall opinion by 1.04 to keep the end result in multiples of 8 percentage points, with the exception of a 100% buy or sell.
That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.Zacks Investment Research is releasing its prediction for CPHI based on the 1-3 month trading system that nearly triples the S&P 500.The Broker Recommendations chart displays the recommendations made by brokerage firms and are not a recommendation to buy or sell a share, but instead indicate of how the broker thinks the company will perform relative to market and other stocks in the industry and sector.
Number of shares sold short was 370.64 Million shares which calculate 205.91 days to cover the short interests.Wall Street analysts have assigned a consensus price target of $4.5 to the stock, which implies a rise of 782.35% to its current value. Government may sell 15-20% in IRCTC via offer for sale Sensex rises 70 points, Nifty50 above 11,350; Vodafone Idea rallies 9% Stocks to watch: Info Edge, Parag Milk, Aurobindo Pharma, Bharat Dynamics & Grasim Busby Antiques and Collectibles is always buying fine quality Fine China, Stoneware and Casual Tableware! Maximum is the strongest this signal has been in the historical period, and minimum is the weakest the signal has been in the historical period. Find the latest analyst research for China Pharma Holdings, Inc. Common Stock (CPHI) at Nasdaq.com. And as of March 30, 2020, it was holding 2.18% of the company’s outstanding shares.The second largest institutional holder is Virtu Financial LLC, which was holding about 35.68 Thousand shares on December 30, 2019.
Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. How good is it? All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. The monthly returns are then compounded to arrive at the annual return. According to our data, China Pharma Holdings, Inc. has a market capitalization of US$12m, and pays its CEO total annual compensation worth US$242k. The pivot point and its support and resistance pairs are defined as follows, where H, L, C are the current day's high, low and close, respectively. China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. This widget shows how the overall Barchart Opinion has changed over the last 3 periods (yesterday, last week and last month).